Obamacare’s insurers struggle for stability amid Trump threats
Obamacare is stuck in limbo, and insurers and state regulators are struggling to set their plans for what’s increasingly shaping up as a chaotic year for the health-care program.
Health Care & Life Sciences
Articles
Lilly uses ‘horny goat weed’ to fend off Cialis royalty demands
Eli Lilly and Co. told a federal jury that a German company is trying to take credit for centuries-old Chinese medicine in seeking royalties on the use of its erectile-dysfunction drug Cialis to treat an enlarged prostate.
Lilly’s rheumatoid arthritis pill rejected by regulators
The drug, which has the proposed brand name Olumiant and is approved for use in Europe, was expected to be a big seller.
Fixes for ‘Obamacare’ markets not enough to impress insurers
The White House remained mum on the biggest concern. Insurers, doctors, hospitals and the business community have asked President Trump to preserve cost-sharing subsidies that pare down high deductibles and copayments for consumers with modest incomes.
Blame game over drug prices escalates with new ad campaign
Broadening its efforts to defuse outrage over skyrocketing prices, the pharmaceutical industry’s lobbying association has started an advertising campaign urging insurers to share with customers more of the benefits of rebates they’ve negotiated.
Indiana needle exchange bill heads to governor, who backs it
The state Senate approved the measure Thursday by a 32-16 vote after lengthy discussion about needle exchanges, which aim to reduce the spread of infectious diseases by providing people with clean syringes and discouraging needle sharing
Marian medical school’s first graduates could fill primary-care dearth
Almost half of graduating students in Marian University’s novice College of Osteopathic Medicine are choosing to serve residencies in family medicine.
Insurance giant buying American Health Network doctor group
In the latest sign of health care consolidation, Indiana’s largest independent physician group has agreed to be acquired by the nation’s largest health insurer for $184 million.
Lilly among firms pulling ads from ‘O’Reilly Factor’
A sexual harassment scandal involving host Bill O’Reilly has prompted major advertisers such as Eli Lilly and Co. and several automakers to drop out. Indianapolis-based Angie’s List is among those sticking with the show.
White House woos GOP lawmakers with revised health care bill
Republicans entertained a fresh White House offer to revise the party's failed health care bill Tuesday as the GOP tried to resuscitate the measure that crashed less than two weeks ago.
Medical device software firm plans to add 120 employees
Indianapolis-based software company Greenlight.guru has moved operations from one downtown facility to another to accommodate expansion.
FOCUS: Biosciences institute’s chief scientific officer aims to foster commercialization
Rainer Fischer’s goal is to spur collaboration in research and commercialization of life sciences products.
Analysts: Anthem likely to pull back from Obamacare in 2018
An exit by Indianapolis-based Anthem Inc. could be devastating to the health care law, limiting coverage options for consumers.
Local Roche units sue pharmacies over alleged test-strip scheme
Two Indianapolis-based subsidiaries of Swiss pharmaceutical giant Roche Group are accusing a group of pharmacies and supply houses of engaging in an elaborate scheme to defraud Roche of millions of dollars worth of sales on diabetes test strips.
Future of ‘abortion reversal’ bill in doubt
Two key Indiana lawmakers said they do not intend to take action on legislation addressing so-called abortion reversal procedures, likely dooming its chances of becoming law this session.
Indiana enrollment in health exchanges plunges 11 percent
As Republicans pushed to end the Affordable Care Act, nearly 22,000 fewer Hoosiers bought health coverage on the exchanges, a decline some say could hurt hospitals.
House Republicans, short of votes, withdraw health care bill
Republican leaders have abruptly pulled their troubled health care overhaul bill off the House floor, short of votes and eager to avoid a defeat for President Donald Trump and GOP leaders.
UPDATE: Lilly to invest $85M in Indy as part of diabetes expansion
The expansion at the Lilly Technology Center southwest of downtown is part of an $850 million investment the company is making this year in its U.S. research labs, manufacturing plants and other operations.
Cancer often comes down to random chance, study says
Lifestyle and heredity get the most blame for cancer, but new research suggests random chance plays a bigger role than people realize.
Holcomb urges Congressional support of jeopardized GOP health care bill
The fate of the Republicans’ health care bill hangs in the balance, but Gov. Eric Holcomb is giving it his support.